Research output: Contribution to journal › Article › peer-review
A novel class of tyrosyl-DNA phosphodiesterase 1 inhibitors that contains the octahydro-2H-chromen-4-ol scaffold. / Li-Zhulanov, Nikolai S.; Zakharenko, Alexandra L.; Chepanova, Arina A. et al.
In: Molecules, Vol. 23, No. 10, 2468, 26.09.2018.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - A novel class of tyrosyl-DNA phosphodiesterase 1 inhibitors that contains the octahydro-2H-chromen-4-ol scaffold
AU - Li-Zhulanov, Nikolai S.
AU - Zakharenko, Alexandra L.
AU - Chepanova, Arina A.
AU - Patel, Jinal
AU - Zafar, Ayesha
AU - Volcho, Konstantin P.
AU - Salakhutdinov, Nariman F.
AU - Reynisson, Jóhannes
AU - Leung, Ivanhoe K.H.
AU - Lavrik, Olga I.
N1 - Publisher Copyright: © 2018 by the authors.
PY - 2018/9/26
Y1 - 2018/9/26
N2 - Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is a DNA repair enzyme that mends topoisomerase 1-mediated DNA damage. Tdp1 is a current inhibition target for the development of improved anticancer treatments, as its inhibition may enhance the therapeutic effect of topoisomerase 1 poisons. Here, we report a study on the development of a novel class of Tdp1 inhibitors that is based on the octahydro-2H-chromene scaffold. Inhibition and binding assays revealed that these compounds are potent inhibitors of Tdp1, with IC50 and KD values in the low micromolar concentration range. Molecular modelling predicted plausible conformations of the active ligands, blocking access to the enzymatic machinery of Tdp1. Our results thus help establish a structural-activity relationship for octahydro-2H-chromene-based Tdp1 inhibitors, which will be useful for future Tdp1 inhibitor development work.
AB - Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is a DNA repair enzyme that mends topoisomerase 1-mediated DNA damage. Tdp1 is a current inhibition target for the development of improved anticancer treatments, as its inhibition may enhance the therapeutic effect of topoisomerase 1 poisons. Here, we report a study on the development of a novel class of Tdp1 inhibitors that is based on the octahydro-2H-chromene scaffold. Inhibition and binding assays revealed that these compounds are potent inhibitors of Tdp1, with IC50 and KD values in the low micromolar concentration range. Molecular modelling predicted plausible conformations of the active ligands, blocking access to the enzymatic machinery of Tdp1. Our results thus help establish a structural-activity relationship for octahydro-2H-chromene-based Tdp1 inhibitors, which will be useful for future Tdp1 inhibitor development work.
KW - Anticancer agent
KW - Biochemical assay
KW - Chemical space
KW - DNA repair enzyme
KW - Molecular modeling
KW - Structural-activity relationships
KW - Synthesis
KW - Tdp1 inhibitor
KW - synthesis
KW - structural-activity relationships
KW - ISOPULEGOL
KW - ANALGESIC ACTIVITY
KW - anticancer agent
KW - molecular modeling
KW - biochemical assay
KW - TDP1
KW - BIOLOGICAL EVALUATION
KW - chemical space
UR - http://www.scopus.com/inward/record.url?scp=85054090656&partnerID=8YFLogxK
U2 - 10.3390/molecules23102468
DO - 10.3390/molecules23102468
M3 - Article
C2 - 30261631
AN - SCOPUS:85054090656
VL - 23
JO - Molecules
JF - Molecules
SN - 1420-3049
IS - 10
M1 - 2468
ER -
ID: 16947686